Baxter reports good results for cell-tissue flu vaccine

07/24/2007 | Chicago Tribune (tiered subscription model)

Baxter International said a Phase I trial showed "strong antibody responses and good tolerability" for its reformulated seasonal flu vaccine made with cell tissues. The company is intent on building its vaccine business, including a vaccine against avian flu, and the cell-based process eliminates the need for chicken eggs and speeds the production process for vaccines.

View Full Article in:

Chicago Tribune (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations